Monopar Therapeutics Inc. - Common Stock (MNPR) — AI analysis & news
Monopar Therapeutics Inc. - Common Stock (MNPR) stock: 4 recent news items, slightly negative aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 4 indexed MNPR stories, aggregate finance-aware sentiment is slightly negative (-0.25 on a -1 to +1 scale).
Latest MNPR news
- Monopar Therapeutics director Christopher Starr sells shares worth $659k By Investing.com - Investing.com Nigeria · Investing.com Nigeria
- Monopar Therapeutics director Christopher Starr sells shares worth $659k By Investing.com - Investing.com India · Investing.com India
- Monopar Therapeutics CEO Robinson sells $2.5m in stock By Investing.com - Investing.com India · Investing.com India
- Monopar Therapeutics CEO Robinson sells $2.5m in stock By Investing.com - Investing.com Canada · Investing.com Canada
FAQ
What is the current sentiment for MNPR stock?
Aggregate finance-aware sentiment across the last 4 indexed MNPR news stories is slightly negative (-0.25 on a -1 to +1 scale).